These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19657770)

  • 1. Premature vascular damage in systemic lupus erythematosus.
    Kaplan MJ
    Autoimmunity; 2009 Nov; 42(7):580-6. PubMed ID: 19657770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
    Kaplan MJ
    Transl Res; 2009 Aug; 154(2):61-9. PubMed ID: 19595437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
    Boffa JJ; Rougier JP; Noël N; Ronco P
    Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
    Tso TK; Huang WN; Huang HY; Chang CK
    Rheumatology (Oxford); 2006 Sep; 45(9):1148-53. PubMed ID: 16527878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
    Rhew EY; Ramsey-Goldman R
    Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
    Von Feldt JM
    Bull NYU Hosp Jt Dis; 2008; 66(3):184-7. PubMed ID: 18937629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.
    Bultink IE
    Arthritis Res Ther; 2010; 12(1):107. PubMed ID: 20236499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination, atherosclerosis and systemic lupus erythematosus.
    Carvalho JF; Pereira RM; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in systemic lupus erythematosus: an update.
    Liu Y; Kaplan MJ
    Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
    Tumurkhuu G; Montano E; Jefferies C
    Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular manifestations of systemic lupus erythematosus].
    Gómez-León Mandujano A; Amezcua-Guerra LM
    Arch Cardiol Mex; 2008; 78(4):421-30. PubMed ID: 19205552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.